Researcher
Robin Maximilian Awad
- Research Expertise:
Expertise: Tumor immunology.
We evaluate the use of single domain antibodies (sdAbs), also known as nanobodies, as targeting moieties for therapeutic and diagnostic applications.
- Keywords:Medicine
- Disciplines:Medical and health sciences, Social sciences
- Users of research expertise:
Expertise: Tumor immunology.
We evaluate the use of single domain antibodies (sdAbs), also known as nanobodies, as targeting moieties for therapeutic and diagnostic applications.
Affiliations
- Laboratory of Molecullar and Cellular Therapy (Research group)
Member
From19 Mar 2021 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Nov 2019 → 31 Aug 2023 - Basic (bio-) Medical Sciences (Department)
Member
From8 Apr 2019 → 31 Oct 2019 - Basic (bio-) Medical Sciences (Department)
Member
From1 Oct 2018 → 31 Oct 2019 - Faculty of Medicine and Pharmacy (Faculty)
Member
From11 Sep 2018 → 14 Jun 2023 - Faculty of Medicine and Pharmacy (Faculty)
Member
From30 Sep 2015 → 27 Jun 2018
Projects
1 - 1 of 1
- Eccentric: Enhancing the function of Cancer Countering Effector cells using Nanobodies Targeting Regulatory Immune CheckpointsFrom1 Nov 2019 → 31 Oct 2023Funding: FWO fellowships
Publications
1 - 10 of 14
- Novel technologies for applying immune checkpoint blockers(2024)Series: International Review of Cell and Molecular Biology
Authors: Robin Maximilian Awad, Karine Breckpot
Number of pages: 100 - In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells(2023)
Authors: Robin Maximilian Awad, Yannick De Vlaeminck, Fien Meeus, Thomas Ertveldt, Katty Zeven, Hannelore Ceuppens, Cleo Goyvaerts, Magali Verdonck, Gustavo Salguero, Geert Raes, et al.
Pages: 1-13 - Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT(2023)
Authors: Katty Zeven, Timo W M De Groof, Hannelore Ceuppens, Robin Maximilian Awad, Thomas Ertveldt, Wout De Mey, Fien Meeus, Geert Raes, Karine Breckpot, Nick Devoogdt
- Eccentric(2023)
Authors: Robin Maximilian Awad, Karine Breckpot, Nick Devoogdt, Yannick De Vlaeminck
Number of pages: 208 - Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment(2022)
Authors: Máté Kiss, Els Lebegge, Aleksandar Murgaski, Helena Van Damme, Daliya Kancheva, Jan Brughmans, Isabelle Scheyltjens, Ali Talebi, Robin Maximilian Awad, Yvon Elkrim, et al.
- Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model(2022)
Authors: Thomas Ertveldt, Lien De Beck, Kirsten De Ridder, Hanne Locy, Wout De Mey, Cleo Goyvaerts, Quentin Lecocq, Hannelore Ceuppens, Yannick De Vlaeminck, Robin Maximilian Awad, et al.
Pages: 1136-1148 - Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma(2022)
Authors: Lien De Beck, Robin Maximilian Awad, Veronica Basso, Noelia Casares, Kirsten De Ridder, Yannick De Vlaeminck, Alessandra Gnata, Cleo Goyvaerts, Quentin Lecocq, Edurne San José-Enériz, et al.
Pages: 1-15 - TNF-alpha-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy(2022)
Authors: Kirsten De Ridder, Hanne Locy, Elisa Piccioni, Miren Ibarra Zuazo, Robin Maximilian Awad, Stefaan Verhulst, Mathias Van Bulck, Yannick De Vlaeminck, Quentin Lecocq, Eva Reijmen, et al.
Pages: 1-15 - Novel 3D Lung Tumor Spheroids for Oncoimmunological Assays(2022)
Authors: Kirsten De Ridder, Navpreet Tung, Jan-Timon Werle, Léa Karpf, Robin Maximilian Awad, Annie Bernier, Hannelore Ceuppens, Hélène Salmon, Cleo Goyvaerts
- Emerging applications of nanobodies in cancer therapy(2022)
Authors: Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens, Thomas Ertveldt, Heleen Hanssens, Quentin Lecocq, Lukasz Mateusiak, Katty Zeven, Hana Valenta, Timo W M De Groof, et al.
Pages: 143-199